Increased Utilization of Primary Care 5 Years Before Diagnosis of Type 2 Diabetes
- 1 January 2005
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (1) , 47-52
- https://doi.org/10.2337/diacare.28.1.47
Abstract
OBJECTIVE—To determine whether case subjects who were later diagnosed with type 2 diabetes utilized primary care differently from control subjects who remained free from diabetes. RESEARCH DESIGN AND METHODS—We conducted a matched cohort study using the U.K. General Practice Research Database. Case subjects were aged 30–89 years, diagnosed with diabetes, and later prescribed oral hypoglycemic drugs between 1997 and 2000. Control subjects, who were matched for age, sex, and general practice, were not diagnosed with diabetes and not treated with oral hypoglycemic drugs or insulin. RESULTS—Data were analyzed for 5,158 case subjects (2,492 women and 2,666 men) and their matched control subjects with a mean age of 63 years. Five years before the date of diagnosis, case subjects consulted more frequently than control subjects (rate ratio [RR] 1.26 [95% CI 1.20–1.33]) and received more prescription items (1.44 [1.36–1.53]). Consultations were increased for a wide range of conditions. The cumulative 5-year prevalence of diagnoses of hypertension or treatment, hyperlipidemia or treatment, obesity, or coronary heart disease or stroke was 66.1% in case subjects and 45.9% in control subjects (1.44 [1.40–1.49]). A medical diagnosis of hyperglycemia or impaired glucose tolerance was highly (>99%) specific for later diagnosis of diabetes. CONCLUSIONS—Primary care consultations and drug utilization are increased from 5 years before diagnosis of diabetes. Diagnoses of hypertension, hyperlipidemia, obesity, or coronary heart disease or stroke have moderate sensitivity for subsequent diabetes but are nonspecific. A diagnosis of hyperglycemia has a high specificity for later detection of diabetes.Keywords
This publication has 18 references indexed in Scilit:
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialThe Lancet, 2003
- Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptionsBMJ, 2002
- The Prevention or Delay of Type 2 DiabetesDiabetes Care, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis.Diabetes Care, 2000
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- United Kingdom Prospective Diabetes Study, 30Archives of Ophthalmology (1950), 1998
- Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in menBMJ, 1995
- Onset of NIDDM occurs at Least 4–7 yr Before Clinical DiagnosisDiabetes Care, 1992